GelSana Therapeutics turns a stretchable wound dressing into a clinician-facing business
GelSana Therapeutics is developing a wound-care business around a material designed to stretch, protect a wound and manage moisture. Its first product, CleraFlex, is a single-use dressing for care directed or supervised by a healthcare professional. The commercial task is as specific as the material: the company needs to reach the clinicians who choose and supervise its use. GelSana has begun selling the product and selected a distributor to help it do that.
A material designed for the wound environment
CleraFlex is made from zwitterionic polymers, materials containing both positive and negative charges. GelSana says the partially hydrated material can donate moisture to a wound or absorb it, while forming a protective barrier.
The dressing is non-sterile and intended for clinical or home-care settings under professional supervision. Its listed uses include diabetic foot ulcers, leg ulcers, pressure sores, surgical wounds and second-degree burns. GelSana says it should not be used on infected wounds unless directed by a healthcare professional.
From laboratory research to clinical use
Founder and CEO Melissa Krebs started GelSana in 2020 after her Colorado School of Mines laboratory studied materials and inflammation. The company says cell tests showed reduced inflammatory markers, while an animal model showed improved healing of diabetic wounds. Those findings are preclinical, not comparative results in people.